Literature DB >> 31055734

Vitamin D3 from Ultraviolet-B Exposure or Oral Intake in Relation to Cancer Incidence and Mortality.

William B Grant1, Meis Moukayed2.   

Abstract

PURPOSE OF REVIEW: This review summarizes the understanding of vitamin D3's role in reducing risk of cancer incidence and mortality. RECENT
FINDINGS: Recent randomized clinical trials and observational studies of participants who took part in vitamin D3 supplementation studies provide increasing evidence that concentrations of serum 25-hydroxyvitamin D3 [25(OH)D3] up to ~ 60 ng/ml are inversely correlated with all cancer and some specific cancers' incidence and death, with a stronger effect on survival and death than on incidence. Mechanisms linking vitamin D3 to effects on cellular proliferation, anti-angiogenesis, and anti-metastasis continue to be found. Vitamin D3 reduces cancer risk causally. Maintaining 25(OH)D3 in the range of 40-60 ng/ml reduces the risk of many cancers. Raising 25(OH)D3 concentrations after diagnosis to that range increases survival rates and could significantly reduce the global burden of cancer incidence and death.

Entities:  

Keywords:  Cancer prevention; Mechanisms; Mendelian randomization; Randomized controlled trials; Vitamin D; Vitamin D deficiency

Mesh:

Substances:

Year:  2019        PMID: 31055734     DOI: 10.1007/s13668-019-0262-5

Source DB:  PubMed          Journal:  Curr Nutr Rep        ISSN: 2161-3311


  72 in total

1.  Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities.

Authors:  Carol E DeSantis; Rebecca L Siegel; Ann Goding Sauer; Kimberly D Miller; Stacey A Fedewa; Kassandra I Alcaraz; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-02-22       Impact factor: 508.702

2.  Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.

Authors:  JoAnn E Manson; Nancy R Cook; I-Min Lee; William Christen; Shari S Bassuk; Samia Mora; Heike Gibson; David Gordon; Trisha Copeland; Denise D'Agostino; Georgina Friedenberg; Claire Ridge; Vadim Bubes; Edward L Giovannucci; Walter C Willett; Julie E Buring
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

3.  Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.

Authors:  G D Díaz; C Paraskeva; M G Thomas; L Binderup; A Hague
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

4.  Do sunlight and vitamin D reduce the likelihood of colon cancer?

Authors:  C F Garland; F C Garland
Journal:  Int J Epidemiol       Date:  1980-09       Impact factor: 7.196

5.  Cancer and vitamin D supplementation: a systematic review and meta-analysis.

Authors:  Beatriz Goulão; Fiona Stewart; John A Ford; Graeme MacLennan; Alison Avenell
Journal:  Am J Clin Nutr       Date:  2018-04-01       Impact factor: 7.045

6.  Plasma 25-hydroxyvitamin D concentration and subsequent risk of total and site specific cancers in Japanese population: large case-cohort study within Japan Public Health Center-based Prospective Study cohort.

Authors:  Sanjeev Budhathoki; Akihisa Hidaka; Taiki Yamaji; Norie Sawada; Sachiko Tanaka-Mizuno; Aya Kuchiba; Hadrien Charvat; Atsushi Goto; Satoshi Kojima; Natsuki Sudo; Taichi Shimazu; Shizuka Sasazuki; Manami Inoue; Shoichiro Tsugane; Motoki Iwasaki
Journal:  BMJ       Date:  2018-03-07

Review 7.  Exploring vitamin D metabolism and function in cancer.

Authors:  Sang-Min Jeon; Eun-Ae Shin
Journal:  Exp Mol Med       Date:  2018-04-16       Impact factor: 8.718

8.  Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis.

Authors:  Xi Zhang; Xuan-Zhang Huang; Wen-Jun Chen; Jian Wu; You Chen; Cong-Cong Wu; Zhen-Ning Wang
Journal:  Oncotarget       Date:  2017-06-29

Review 9.  The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention.

Authors:  Hui Guo; Jing Guo; Wenli Xie; Lingqin Yuan; Xiugui Sheng
Journal:  J Ovarian Res       Date:  2018-08-29       Impact factor: 4.234

10.  Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Authors:  Jue-Sheng Ong; Gabriel Cuellar-Partida; Yi Lu; Peter A Fasching; Alexander Hein; Stefanie Burghaus; Matthias W Beckmann; Diether Lambrechts; Els Van Nieuwenhuysen; Ignace Vergote; Adriaan Vanderstichele; Jennifer Anne Doherty; Mary Anne Rossing; Jenny Chang-Claude; Ursula Eilber; Anja Rudolph; Shan Wang-Gohrke; Marc T Goodman; Natalia Bogdanova; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo B Runnebaum; Natalia Antonenkova; Ralf Butzow; Arto Leminen; Heli Nevanlinna; Liisa M Pelttari; Robert P Edwards; Joseph L Kelley; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Rikki Cannioto; Estrid Høgdall; Claus K Høgdall; Allan Jensen; Graham G Giles; Fiona Bruinsma; Susanne K Kjaer; Michelle At Hildebrandt; Dong Liang; Karen H Lu; Xifeng Wu; Maria Bisogna; Fanny Dao; Douglas A Levine; Daniel W Cramer; Kathryn L Terry; Shelley S Tworoger; Meir Stampfer; Stacey Missmer; Line Bjorge; Helga B Salvesen; Reidun K Kopperud; Katharina Bischof; Katja Kh Aben; Lambertus A Kiemeney; Leon Fag Massuger; Angela Brooks-Wilson; Sara H Olson; Valerie McGuire; Joseph H Rothstein; Weiva Sieh; Alice S Whittemore; Linda S Cook; Nhu D Le; C Blake Gilks; Jacek Gronwald; Anna Jakubowska; Jan Lubiński; Tomasz Kluz; Honglin Song; Jonathan P Tyrer; Nicolas Wentzensen; Louise Brinton; Britton Trabert; Jolanta Lissowska; John R McLaughlin; Steven A Narod; Catherine Phelan; Hoda Anton-Culver; Argyrios Ziogas; Diana Eccles; Ian Campbell; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; Susan J Ramus; Anna H Wu; Agnieszka Dansonka-Mieszkowska; Jolanta Kupryjanczyk; Agnieszka Timorek; Lukasz Szafron; Julie M Cunningham; Brooke L Fridley; Stacey J Winham; Elisa V Bandera; Elizabeth M Poole; Terry K Morgan; Harvey A Risch; Ellen L Goode; Joellen M Schildkraut; Celeste L Pearce; Andrew Berchuck; Paul Dp Pharoah; Georgia Chenevix-Trench; Puya Gharahkhani; Rachel E Neale; Penelope M Webb; Stuart MacGregor
Journal:  Int J Epidemiol       Date:  2016-09-04       Impact factor: 7.196

View more
  4 in total

Review 1.  Vitamin D testing: advantages and limits of the current assays.

Authors:  Barbara Altieri; Etienne Cavalier; Harjit Pal Bhattoa; Faustino R Pérez-López; María T López-Baena; Gonzalo R Pérez-Roncero; Peter Chedraui; Cedric Annweiler; Silvia Della Casa; Sieglinde Zelzer; Markus Herrmann; Antongiulio Faggiano; Annamaria Colao; Michael F Holick
Journal:  Eur J Clin Nutr       Date:  2020-01-06       Impact factor: 4.016

Review 2.  Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms.

Authors:  Andraž Dovnik; Nina Fokter Dovnik
Journal:  Cells       Date:  2020-02-01       Impact factor: 6.600

3.  Linking the metabolic syndrome and obesity with vitamin D status: risks and opportunities for improving cardiometabolic health and well-being.

Authors:  Meis Moukayed; William B Grant
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-16       Impact factor: 3.168

Review 4.  Vitamin D modulation and microRNAs in gastric cancer: prognostic and therapeutic role.

Authors:  Elena Gallardo Martin; Antia Cousillas Castiñeiras
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.